Xenon Pharmaceuticals Inc. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Collaboration Agreements (2 contracts)
- Indemnification Agreements (1)
- Sales Agreements (5)
- Termination Agreements (2)
- Amendment No. 1 to the At-the-Market Equity Offering Sales Agreement, dated March 1, 2022, by and among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company,... (Filed With SEC on March 1, 2022)
- Amendment #2, dated February 25, 2022, to the License and Collaboration Agreement, dated December 2, 2019, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc (Filed With SEC on March 1, 2022)
- Termination Agreement, dated August 6, 2021, by and among Xenon Pharmaceuticals Inc., Genentech, Inc. and F. Hoffmann-La Roche Ltd (Filed With SEC on August 11, 2021)
- Amendment #1, dated January 13, 2021, to the License and Collaboration Agreement, dated December 2, 2019, by and between Xenon Pharmaceuticals Inc. and Neurocrine Biosciences, Inc (Filed With SEC on January 14, 2021)
- At-the-Market Equity Offering Sales Agreement dated as of August 6, 2020, by and among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on August 6, 2020)
- At-the-Market Equity Offering Sales Agreement dated as of November 5, 2019, by and among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on November 5, 2019)
- At-the-Market Equity Offering Sales Agreement, dated as of July 11, 2018, by and among Xenon Pharmaceuticals Inc., Jefferies LLC and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on July 12, 2018)
- At-the-Market Equity Offering Sales Agreement, dated as of May 8, 2018, between Xenon Pharmaceuticals Inc. and Stifel, Nicolaus & Company, Incorporated (Filed With SEC on May 8, 2018)
- Termination Agreement by and among Xenon Pharmaceuticals Inc., Teva Pharmaceuticals International GmbH and Teva Canada Limited dated March 7, 2018 (Filed With SEC on March 7, 2018)
- INDEMNIFICATION AGREEMENT BETWEEN XENONPHARMACEUTICALS INC. AND MADE AS OF , 2014 INDEMNIFICATION AGREEMENT, (Filed With SEC on October 6, 2014)